Buy Biltricide

Biltricide

What is Biltricide?

Biltricide is a prescription antiparasitic medication that contains praziquantel as its active ingredient. It is supplied as a 600 mg oral pill and is approved for use in Hong Kong under the regulatory oversight of the Drug Office of the Department of Health. The product is marketed by Merck & Co., Inc. as a treatment for infections caused by various trematodes (flukes) and cestodes (tapeworms).

How Biltricide Works in the Body

Praziquantel targets parasitic flatworms by increasing the permeability of their cell membranes to calcium ions. This rapid influx of calcium leads to:

• Muscle contraction and paralysis of the worm, preventing it from maintaining its position in the host.
• Disruption of the worm’s tegument, exposing it to the host’s immune system.
• Accelerated loss of viability, allowing the immune system to clear the dead parasite.

The drug is rapidly absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 1-2 hours. Its bioavailability is enhanced when taken with food. Praziquantel is extensively metabolized by hepatic cytochrome P450 enzymes, primarily CYP3A4, and the metabolites are excreted mainly via the kidneys.

Treating Parasitic Infections with Biltricide

Biltricide (praziquantel) is approved by the Food and Health Bureau in Hong Kong for the following indications:

• Schistosomiasis caused by Schistosoma species (e.g., S. mansoni, S. haematobium, S. japonicum).
• Fascioliasis (Fasciola hepatica infection).
• Clonorchiasis (Clonorchis sinensis infection).
• Paragonimiasis (Paragonimus species infection).
• Taeniasis (intestinal tapeworm infection) caused by Taenia saginata or Taenia solium.

These indications are based on clinical trials demonstrating effective parasite clearance after a single oral dose (or a short course) of praziquantel.

Evidence-Based Off-Label Uses

Research has explored praziquantel for additional parasitic conditions:

• Neurocysticercosis (brain infection with Taenia solium cysts) - supported by multiple randomized trials. Regulatory status: Not formally approved for this indication in Hong Kong; use requires specialist supervision.

• Echinococcosis (hydatid disease) - limited case series suggest benefit when combined with albendazole. Regulatory status: Off-label; clinicians must weigh risks and monitor hepatic function.

Disclaimer: Off-label use of Biltricine requires medical supervision and individualized risk assessment.

Who Should (Not) Use Biltricide?

Ideal Patient Profile

• Adults or children who have been diagnosed with a susceptible trematode or cestode infection.
• Individuals able to swallow a whole pill and follow dosing instructions.

Absolute Contraindications

• Known hypersensitivity to praziquantel or any of the tablet’s inactive ingredients.
• Severe hepatic impairment (Child-Pugh class C) where drug metabolism cannot be assured.

Relative Contraindications

• Pregnancy - Praziquantel is classified as pregnancy category B, but caution is advised, especially during the first trimester.
• Breastfeeding - Small amounts are excreted in breast milk; risk versus benefit should be evaluated.
• Severe renal dysfunction - Dose adjustment may be needed.
• Concurrent use of strong CYP3A4 inducers (e.g., carbamazepine, rifampicin) which can lower praziquantel levels.

Special Populations

• Pediatric patients - Approved for children ≥4 years; dosing is weight-based.
• Elderly - No specific dose change, but monitor for hepatic or renal decline.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Abdominal discomfort or pain
• Nausea and vomiting
• Headache
• Dizziness or light-headedness
• Fatigue or malaise

These effects are usually transient and resolve without intervention.

Serious Adverse Events

• Severe allergic reactions (rash, urticaria, anaphylaxis) - seek immediate medical care.
• Hepatotoxicity (elevated liver enzymes) - monitor liver function in prolonged therapy.
• Rare cardiac arrhythmias reported in high-dose regimens.

Drug Interactions

• CYP3A4 inducers (e.g., carbamazepine, rifampicin) may decrease praziquantel plasma concentrations, reducing efficacy.
• Warfarin - Praziquantel can potentiate anticoagulant effect; INR should be monitored.
• Antiepileptic drugs - May alter seizure threshold; clinical judgment required.

Food and Lifestyle Interactions

• Take with food to improve absorption; high-fat meals increase bioavailability.
• Alcohol - No direct contraindication, but excessive intake may exacerbate gastrointestinal side effects.
• Operating machinery - Dizziness may impair safe driving; avoid hazardous tasks until tolerance is known.

If a patient is unsure about any other medication, supplement, or herbal product, they should discuss it with a healthcare provider before starting Biltricide.

How to Take Biltricide

• Standard dosing for schistosomiasis: 40 mg/kg as a single oral dose (e.g., a 70 kg adult would take approximately 2,800 mg, split into three 600 mg tablets).
• Other infections (e.g., fascioliasis, clonorchiasis): 25 mg/kg three times daily for one day (total 75 mg/kg).

Administration tips

• Swallow tablets whole; do not chew or crush.
• Take with a full glass of water and a meal.
• Store tablets at room temperature, away from moisture and direct sunlight.

Missed dose

• If a dose is missed, take it as soon as remembered unless the next scheduled dose is due; do not double the dose.

Overdose

• Symptoms may include severe nausea, vomiting, dizziness, and seizures.
• Seek emergency medical attention; supportive care and gastric lavage may be employed.

Discontinuation

• No tapering is required; treatment courses are short. Abrupt cessation is safe after the prescribed course.

Note: Dosing must be individualized by the prescribing clinician based on body weight, infection type, and patient health status.

Monitoring and Follow-Up

• Parasitological assessment: Stool or urine examinations are recommended 2-4 weeks after treatment to confirm parasite clearance.
• Liver function tests: Baseline and post-treatment labs for patients with hepatic disease or on prolonged courses.
• Pregnant or lactating women: Close obstetric monitoring if treatment is deemed necessary.

Regular follow-up with a healthcare professional ensures therapeutic success and early detection of any adverse reactions.

Storage and Handling

• Store Biltricide tablets at room temperature (20-25 °C), protected from moisture and light.
• Keep out of reach of children; use child-proof containers.
• Dispose of unused tablets according to local pharmacy waste guidelines or return to a medication take-back program.

Medication-Specific Glossary

Praziquantel

An antiparasitic agent that disrupts calcium ion homeostasis in flatworms, causing paralysis and death.

Trematode

A class of parasitic flatworms (flukes) that includes species responsible for schistosomiasis, clonorchiasis, and fascioliasis.

Bioavailability

The proportion of an administered dose that reaches systemic circulation unchanged; for praziquantel, it is increased when taken with food.

CYP3A4

A liver enzyme responsible for metabolizing many drugs, including praziquantel; its activity can be altered by other medications.

Schistosomiasis

A disease caused by Schistosoma species, characterized by urinary or intestinal symptoms, and potentially leading to organ damage if untreated.

Medical Disclaimer

This article provides educational information about Biltricide and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.